Horizon pharma plc

Major-Pharmaceuticals

HZNP


Connaught House
Dublin , 4

Executive/
Director

Price

  • Last Close
  • $ 116.3
    $ +0.05 0.04 %
    Oct 5, 2023
  • 52-Week High/Low
  • $116.3 - $112.74
  • YTD
  • 0%

  • Trading Volume
  • 28,881,250
  • Market Cap Full
  • $ 26.6B
  • Shares Outstanding
  • 229M
    Aug 2, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 101.5% -23.5% -8.7% -2.7% 35.3% -5% 25.8% -3.1% -4.1% -
Q2 33.8% -0.6% -19.7% 20% -7.9% 4% 1.7% -24.2% -5.8% -
Q3 -43% 10.1% 6.8% 16.7% 11.3% 8% 17% -22.4% 12.5% -
Q4 9.3% -10.8% 8.2% 3.7% 31.9% -5.8% -0.9% 83.9% 0.3% -
J F M A M J J A S O N D
2024 - - - - - - - - - - - -
2023 -3.6% -0.2% -0.3% 1.9% -10% 2.8% -2.5% 12.4% 2.6% 0.5% - -
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    69%68%-25%-10%34%84%103%48%5%2%0%

Earnings

2015 2016 2017 2018 2019 2020 2021 2022
Q1 0.16 0.34 0.21 -0.96 -0.19 - - -
Q2 0.29 0.42 0.41 -0.2 -0.03 - - -
Q3 0.59 0.56 0.26 0.15 0.64 1.74 - -
Q4 0.52 0.50 0.29 0.56 2.9 1.81 2.27 2.22
A 1.6 1.8 1.2 -0.2 2.9 1.8 2.3 2.2

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 169.6 189.9 224 229.2 228.4
Jun 165 184.9 190.8 224.8 229.9 228.6
Sep 166.6 186.4 206.5 225.9 230.4 229
Dec 167.6 187.3 220.7 226.8 226.6 -

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover 5.4 3.5 7.1 6.7 8.3
Fixed Asset Turnover 2.7 2.5 9 16.7 28.1
Total Asset Turnover 0.4 0.4 0.4 0.3 0.3
Leverage
Debt Ratio 0.7 0.9 0.3 0.8 1.2
Debt – Equity Ratio 0.5 0.6 0.3 0.6 1.8
Interest Coverage 6.4 60.3 4.9 -0.3 -
Equity multiplier 0.3 0.3 0.1 - -